Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
Background: TNFα inhibitors are regularly used to treat autoimmune diseases. Tuberculosis (TB) and viral hepatitis B are considered potential infectious complications, and screening and surveillance are therefore recommended. Current guidelines do not take into account regional differences in endemi...
Saved in:
Main Authors: | Nina Jahnich (Author), Peter D. Arkwright (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
by: José Luis Callejas-Rubio, et al.
Published: (2008) -
Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors
by: Ena Masukawa, et al.
Published: (2021) -
Genetic Polymorphism of Tumor Necrosis Factor-Alpha, Interferon-Gamma and Interleukin-10 and Association With Risk of Mycobacterium Tuberculosis Infection
by: Gashaw Adane MSc, et al.
Published: (2021) -
Genetic Polymorphism of Tumor Necrosis Factor-Alpha, Interferon-Gamma and Interleukin-10 and Association With Risk of Mycobacterium Tuberculosis Infection
by: Gashaw Adane MSc, et al.
Published: (2021) -
The concentration of tumor necrosis factor alpha in periapical lesions
by: Popović Jelena, et al.
Published: (2014)